Navigation Links
Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models
Date:4/21/2009

by blocking the activity of at least three "inhibitors of apoptosis proteins" or IAPs (including XIAP, c-IAP1, and c-IAP2) to create conditions in which apoptosis can proceed. As such, AT-406 is considered a multi-IAP antagonist. IAPs are key components of the complex cascade of protein signaling that activates enzymes called caspases to initiate breakdown of the cancer cell. AT-406 is thought to mimic the activity of Smac (second mitochondria-derived activator of caspases) by binding to XIAP and preventing it from inhibiting caspase activation. Upon binding, AT-406 induces rapid degradation of cIAP-1/2 proteins and promotes apoptosis through activation of caspase-8 and the death-receptor complex.

AT-406 is in late-stage preclinical development and has demonstrated strong single-agent antitumor activity in multiple xenograft models of human cancer, including breast cancer, pancreatic cancer, prostate cancer, and lung cancer. AT-406 has also been shown to work synergistically with conventional chemotherapeutic and targeted agents (such as tyrosine kinase inhibitors) in preclinical tumor models.

Other Research Including AT-101

Ascenta Therapeutics also announced that researchers from the University of Pennsylvania presented results at AACR from an independent laboratory study examining the role of Bcl-2 homology (BH) family proteins in the development of chemotherapy resistance in neuroblastoma (Abstract # 3269). Using human-derived neuroblastoma cell lines, these investigators demonstrated differential resistance patterns to inhibitors of the Bcl-2 family proteins based on the relative BH proteins expressed (specifically, Mcl-1 or Bcl-2). They showed that Ascenta's small molecule pan-Bcl-2 inhibitor, AT-101, had preferential inhibition in Mcl-1 predominant lines. They concluded that compounds with activity against Mcl-1 may be useful in the treatment of high-risk neuroblastoma and warrant further stu
'/>"/>

SOURCE Ascenta Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
2. Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting
3. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
4. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
5. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
6. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
7. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
8. Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market
9. TorreyPines Therapeutics Receives Notice of Non-Compliance with Nasdaq Continued Listing Requirements
10. Cornerstone Therapeutics to Present at BioCenturys 2009 Future Leaders in the Biotech Industry Conference
11. Arno Therapeutics Reports 2008 Year-End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... -- The report "Biolubricants Market by Type ... Chainsaw oils, Mold Release Agents), End Use (Industrial, Commercial ... and Forecasts to 2020" published by MarketsandMarkets, The Biolubricants ... at a CAGR of 6.27% between 2015 and 2020. ...   66 Figures spread through 170 Pages and in-depth ...
(Date:6/25/2015)... -- Current asthma medications, which work by suppressing ... the airways, can stop working over time. A ... Hospital and Harvard Medical School supports a surprising ... nerve endings in the lungs that help drive ... journal Neuron on June 25, the ...
(Date:6/25/2015)... 25, 2015  The Galien Awards Committee announced today ... and Medical Genetics at the University of Washington and ... Award at the ninth annual Prix Galien ... The Pro Bono Humanum Award recognizes ground-breaking efforts ... woman recipient of the award.   The Galien ...
(Date:6/25/2015)... San Francisco, CA (PRWEB) , ... June 25, ... ... the uBiome Studies Portal to support citizen science opportunities in microbiome research, on ... is a microbiome sequencing service that made history with a record-breaking campaign to ...
Breaking Biology Technology:Biolubricants Market Worth $2,972.13 Million by 2020 2Biolubricants Market Worth $2,972.13 Million by 2020 3Targeting Nerve Endings To Curb Allergic Asthma 2Targeting Nerve Endings To Curb Allergic Asthma 3Targeting Nerve Endings To Curb Allergic Asthma 4Targeting Nerve Endings To Curb Allergic Asthma 5The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 3uBiome Launches Studies Portal to Support Microbiome Research 2uBiome Launches Studies Portal to Support Microbiome Research 3
... NEW YORK, Aug. 1, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental ... or "AOBO"), a pharmaceutical company dedicated to improving health ... range of prescription and over the counter ("OTC") products, ... 2011 financial results on Tuesday, August 9, 2011, after ...
... Researchers have developed a toolkit that enables them to ... Led by Susan Dymecki, a professor of ... serotonin-producing neurons, observing how mice behave in a normal ... While their findings affirm earlier studies, the researchers used ...
... When normal proteins form protein clumps in the body, ... "amyloids," are closely associated with Alzheimer,s disease and type ... knew how these proteins form clumps, then they might ... The physicist Adrian Keller and his colleagues at the ...
Cached Biology Technology:American Oriental Bioengineering to Announce Second Quarter 2011 Financial Results on August 9, 2011 2Researchers target, switch off serotonin-producing neurons in mice 2Researchers target, switch off serotonin-producing neurons in mice 3In the pursuit of dangerous clumps 2In the pursuit of dangerous clumps 3
(Date:6/18/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market announces that its Wocket® smart wallet will be ... Mark", scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive ... NXT-ID, Inc.,s CEO Gino Pereira will be discussing ...
(Date:6/17/2015)... GERMANTOWN, Maryland , and HILDEN, Germany ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) today launched ... DNA evidence in forensic laboratories in the United ... integrated solution to simultaneously analyze multiple key genomic markers (short ... Investigator ® Quality Sensor to evaluate the quality of ...
(Date:6/17/2015)... Fla. , June 17, 2015  Crossmatch™, ... today announced that its U.are.U ® 4500 ... Togo,s Eateries, Inc., a ... sandwich chain, to increase security, improve accountability and ... readers enable instant, non-repudiable identity confirmation for employee ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
... Sildenafil and other "impotence drugs" that boost the production of ... an erection now also show promise in unmasking cancer cells ... say scientists at the Johns Hopkins Kimmel Cancer Center. , ... tumors showed that tumor size decreased two- and threefold in ...
... many as 18 percent of adults who have no history ... stroke, according to results of a large national study published ... one of the JAMA/Archives journals. , Using brain imaging to ... have had an undiagnosed or silent stroke, according to background ...
... in imaging software and machinery, also known as a 64-slice ... and accurate means of tracking blood that has been slowed ... it took them less than half the time of exercise ... warning of vessels more likely to become blocked and cause ...
Cached Biology News:'Erectile dysfunction' drugs heighten natural anti-cancer activity 2Stroke symptoms common among general population 2Fast test for low blood flow in dogs detects early heart trouble 2Fast test for low blood flow in dogs detects early heart trouble 3Fast test for low blood flow in dogs detects early heart trouble 4
Identify and characterize Phosphoinositide (PI(4,5)P2) binding...
Recommended fro Western blotting application...
... Immunogen corresponds to amino acids 2-105 ... has been successfully used in Western blot, ... blot, this antibody detects an ~ 60 ... has also been used in immunoprecipitation and ...
... KLF15 is a Cys2-His2 zinc finger gene. ... liver, kidneys, heart, and skeletal muscle. ... produced in rabbits immunized with a synthetic ... KLF15 with an internal ID of P03590 ...
Biology Products: